All Stories

  1. Highly Hydrophilic Gold Nanoparticles as Carrier for Anticancer Copper(I) Complexes: Loading and Release Studies for Biomedical Applications
  2. Syntheses and Biological Studies of Cu(II) Complexes Bearing Bis(pyrazol-1-yl)- and Bis(triazol-1-yl)-acetato Heteroscorpionate Ligands
  3. Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells
  4. Syntheses and biological studies of nitroimidazole conjugated heteroscorpionate ligands and related Cu(I) and Cu(II) complexes
  5. New insights in Au-NHCs complexes as anticancer agents
  6. Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)4]PF6 and [Au(P)4]PF6 (P = thp or PTA) Anticancer Complexes
  7. Novel antitumor copper(ii) complexes designed to act through synergistic mechanisms of action, due to the presence of an NMDA receptor ligand and copper in the same chemical entity
  8. The first water-soluble copper(I) complexes bearing sulfonated imidazole- and benzimidazole-derived N-heterocyclic carbenes: Synthesis and anticancer studies
  9. Therapeutic potential of the phosphino Cu(I) complex (HydroCuP) in the treatment of solid tumors
  10. Novel metalloantimalarials: Transmission blocking effects of water soluble Cu(I), Ag(I) and Au(I) phosphane complexes on the murine malaria parasite Plasmodium berghei
  11. The hydridotris(3-nitro-1,2,4-triazol-1-yl)borate, a new nitro-substituted electron withdrawing polydentate “scorpionate”-type ligand and related copper and silver phosphane complexes
  12. The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor
  13. Recent Advances in Medicinal Applications of Coinage-Metal (Cu and Ag) N-Heterocyclic Carbene Complexes
  14. Insights into the cytotoxic activity of the phosphane copper(I) complex [Cu(thp)4][PF6]
  15. Boron-Centered Scorpionate-Type NHC-Based Ligands and Their Metal Complexes
  16. Novel multicharged silver(I)–NHC complexes derived from zwitterionic 1,3-symmetrically and 1,3-unsymmetrically substituted imidazoles and benzimidazoles: Synthesis and cytotoxic properties
  17. Novel triazolium based 11th group NHCs: synthesis, characterization and cellular response mechanisms
  18. Electrospray ionization multi-stage mass spectrometric study of the interaction products of the cytotoxic complex [Cu(thp)4][PF6] with methionine-rich model peptides
  19. The Combined Therapeutical Effect of Metal-based Drugs and Radiation Therapy: The Present Status of Research
  20. In Vitroandin VivoAnticancer Activity of Copper(I) Complexes with Homoscorpionate Tridentate Tris(pyrazolyl)borate and Auxiliary Monodentate Phosphine Ligands
  21. Advances in Copper Complexes as Anticancer Agents
  22. Synthesis and in vitro antitumor activity of water soluble sulfonate- and ester-functionalized silver(I) N-heterocyclic carbene complexes
  23. The relationship between electrospray ionization behavior and cytotoxic activity of [MI(P)4]+-type complexes (M = Cu, Ag and Au; P = tertiary phosphine)
  24. Neutral and charged phosphine/scorpionate copper(I) complexes: Effects of ligand assembly on their antiproliferative activity
  25. Synchrotron radiation X-ray absorption spectroscopic studies in solution and electrochemistry of a nitroimidazole conjugated heteroscorpionate copper(II) complex
  26. Synthesis and Biological Activity of Ester- and Amide-Functionalized Imidazolium Salts and Related Water-Soluble Coinage Metal N-Heterocyclic Carbene Complexes
  27. A novel copper complex induces paraptosis in colon cancer cells via the activation of ER stress signalling
  28. Biomimetic Applications of Metal Systems Supported by Scorpionates
  29. Halide and Nitrite Recognizing Hexanuclear Metallacycle Copper(II) Pyrazolates
  30. In vitro antitumour activity of water soluble Cu(I), Ag(I) and Au(I) complexes supported by hydrophilic alkyl phosphine ligands
  31. Silver(I) and copper(I) complexes supported by 1,3,5-triazapentadienyl ligands
  32. Nitroimidazole and glucosamine conjugated heteroscorpionate ligands and related copper(ii) complexes. Syntheses, biological activity and XAS studies
  33. A study on the coordinative versatility of new N,S-donor macrocyclic ligands: XAFS, and Cu2+ complexation thermodynamics in solution
  34. ChemInform Abstract: Chemistry and Relevant Biomimetic Applications of Group 6 Metals Systems Supported by Scorpionates
  35. Synthesis and Properties of Poly(pyrazolyl)borate and Related Boron-Centered Scorpionate Ligands. Part B: Imidazole-, Triazole- and Other Heterocycle-Based Systems
  36. Synthesis and Properties of Poly(pyrazolyl)borate and Related Boron-Centered Scorpionate Ligands. Part A: Pyrazole-Based Systems
  37. Scorpionates bearing nitro substituents: mono-, bis- and tris-(3-nitro-pyrazol-1-yl)borate ligands and their copper(i) complexes
  38. Editorial [Hot topic: “Applications of Scorpionate Ligands in Enzyme Modeling and Biological Studies” (Guest Editors: Carlo Santini and Maura Pellei)]
  39. Chemistry and Relevant Biomimetic Applications of Group 6 Metals Systems Supported by Scorpionates
  40. XAFS studies on copper(I) complexes containing scorpionate ligands
  41. Cu K-edge EXAFS on copper(I) complexes containing dihydridobis(3-nitro-1,2,4-triazol-1-yl)borate and bis(1,2,4-triazol-1-yl)acetate ligand: Evidence for the Cu–O interaction
  42. Copper(I) Isocyanide and Phosphane Complexes of Fluorinated Mono- and Bis(pyrazolyl)borates
  43. Trinuclear copper(I) complexes with triscarbene ligands: catalysis of C–N and C–C coupling reactions
  44. Sulfonate- or carboxylate-functionalized N-heterocyclic bis-carbene ligands and related water soluble silver complexes
  45. Synthesis and characterization of the copper(ii) complexes of new N2S2-donor macrocyclic ligands: synthesis and in vivo evaluation of the64Cu complexes
  46. Copper in diseases and treatments, and copper-based anticancer strategies
  47. Novel scorpionate-type triscarbene ligands and their silver and gold complexes
  48. Unsymmetrical 3- and 5-substituted bis(pyrazolyl)borate system
  49. New homoleptic carbene transfer ligands and related coinage metal complexes
  50. Copper(I)–organophosphine complexes of bis(3,5-dimethylpyrazol-1-yl)dithioacetate ligand
  51. Di- and tri-organotin(IV) complexes of the new bis(1-methyl-1H-imidazol-2-ylthio)acetate ligand and the decarboxylated analogues
  52. In Vitro Antitumor Activity of the Water Soluble Copper(I) Complexes Bearing the Tris(hydroxymethyl)phosphine Ligand
  53. Synthesis and spectroscopic characterization of new triorganotin(IV) complexes with the bis(1-methyl-1H-imidazol-2-ylthio)acetate ligand: effects on trout erythrocyte components
  54. Synthesis, in vitro and in vivo characterization of 64Cu(I) complexes derived from hydrophilic tris(hydroxymethyl)phosphane and 1,3,5-triaza-7-phosphaadamantane ligands
  55. Small Scorpionate Ligands:  Silver(I)-Organophosphane Complexes of 5-CF 3 -Substituted Scorpionate Ligand Combining a B−H···Ag Coordination Motif
  56. Synthesis and structural studies of a 1:2 adduct of silver(I) tetrakis(pyrazolyl)borate(III) with a tertiary phosphine
  57. Silver(I)-organophosphane complexes of the dihydridobis(3-nitro-1,2,4-triazolyl)borate ligand. X-ray crystal structure of {[H2B(tzNO2)2]Ag[P(m-tolyl)3]2} with the scorpionate ligand co-ordinated in an unidentate κ1-N fashion
  58. Silver(i)-organophosphane complexes of electron withdrawing CF3- or NO2-substituted scorpionate ligands
  59. Synthesis, Characterization, and in Vitro Antitumor Properties of Tris(hydroxymethyl)phosphine Copper(I) Complexes Containing the New Bis(1,2,4-triazol-1-yl)acetate Ligand
  60. Synthesis and characterization of divalent metal complexes containing the heteroscorpionate ligand dihydrobis(3-carboxyethyl-5-methylpyrazolyl)borate
  61. Oxo-rhenium(V) compounds containing bis(3,5-dimethylpyrazol-1-yl)acetate scorpionate ligand
  62. Synthesis and characterization of new organotin(IV) complexes with polyfunctional ligands
  63. New copper(I) phosphane complexes of dihydridobis(3-nitro-1,2,4-triazolyl)borate ligand showing cytotoxic activity
  64. Silver(I) poly(1,2,3-benzotriazolyl)borate complexes containing mono- and bidentate phosphine coligands
  65. New triorganotin(IV) complexes of a polyfunctional S,N,O-ligand
  66. Novel Rhenium(V) Oxo Complexes Containing Bis(pyrazol-1-yl)acetate and Bis(pyrazol-1-yl) Sulfonate as Tripodal N,N,O-heteroscorpionate Ligands
  67. Tin(IV) and organotin(IV) derivatives of bis(pyrazolyl)acetate: Synthesis, spectroscopic characterization and behaviour in solution.
  68. Synthesis, characterization and hydrolytic behavior of new bis(2-pyridylthio)acetate ligand and related organotin(IV) complexes
  69. Synthesis and spectroscopic characterization of new organotin(IV) complexes with bis(3,5-dimethylpyrazol-1-yl)dithioacetate
  70. Silver (I) poly(1,2,4-triazolyl)borate complexes containing monodentate phosphane ligands
  71. The First Nitro-Substituted Heteroscorpionate Ligand
  72. Silver(I) bis(1,2,4-triazolyl)borate complexes containing bidentate phosphine ligands
  73. Synthesis, spectroscopic characterization (IR,1H,13C and119Sn NMR, electrospray mass spectrometry) and toxicity of new organotin(IV) complexes withN,N′,O- andN,N′,S-scorpionate ligands
  74. Syntheses and spectroscopic and structural characterization of silver(I) complexes containing tris(isobutyl)phosphine and poly(azol-1-yl)borates
  75. A new ester substituted heteroscorpionate ligand
  76. New (diphenylphosphane)benzoic acid copper(I) derivatives of “scorpionate” ligands with superoxide scavenging activity
  77. New N,N,O,O functionalized heteroscorpionate ligands and related Zn(II) and Cd(II) derivatives
  78. Gold derivatives of scorpionates: comparison with the other coinage metal poly(pyrazolyl)borate analogues
  79. Synthesis, characterization and antioxidant activity of new copper(i) complexes of scorpionate and water soluble phosphane ligands
  80. Copper and silver derivatives of scorpionates and related ligands
  81. Crystal Structures and Vibrational and Solution and Solid-State (CPMAS) NMR Spectroscopic Studies in Triphenyl Phosphine, Arsine, and Stibine Silver(I) Bromate Systems, (R3E)xAgBrO3(E = P, As, Sb;x= 1−4)
  82. Synthesis and characterization of new copper(I) complexes containing 4-(diphenylphosphane)benzoic acid and “scorpionate” ligands with “in vitro” superoxide scavenging activity
  83. Synthesis and solution studies by electrospray mass spectroscopy of new bis(imidazolyl)borate organotin(IV) complexes
  84. Polypyrazolylborate and Scorpionate Ligands
  85. Variable Coordination Modes of NO 2 - in a Series of Ag(I) Complexes Containing Triorganophosphines, -arsines, and -stibines. Syntheses, Spectroscopic Characterization (IR, 1 H and 31 P NMR, Electrospray Ionization Mass), and Structures of [AgNO 2 (R ...
  86. Unprecedented phosphino copper(I) derivatives of tris(pyrazolyl)methanesulfonate ligand co-ordinated to metal in an unusual κ3-N,N′,O fashion
  87. Poly(1,2,3-benzotriazolyl)borate complexes with copper(I) and tri-organophosphane: an unprecedented κ1-coordination of [H2B(btz)2] (btz=1,2,3-benzotriazolyl) in the X-ray crystal structure of [Cu(PBn3)2{(btz)BH2(btz)}]
  88. Copper(i) coordination polymers and mononuclear copper(i) complexes built from poly(1,2,4-triazolyl)borate ligands and tri-organophosphinesElectronic supplementary information available: conductivity data for compounds 1–14. See http://www.rsc.org/supp...
  89. Synthesis and characterization of the first poly(imidazolyl)borate organotin(IV) complex exhibiting a polymeric chain structure
  90. The reactivity of hydrotris(3-methyl-2-thioxo-1-imidazolyl)borate (Tm) towards organotin(IV) acceptors. An unprecedented monodentate coordination mode of Tm ligand
  91. Synthesis, reactivity and solid-state structural studies of new phosphino copper(I) derivatives of hydrotris(3-methyl-2-thioxo-1-imidazolyl)borate
  92. Structure and volatility of copper complexes containing pyrazolyl-based ligands
  93. Solution and solid-state structural properties of silver(I) poly(pyrazolyl)borate compounds with bidentate diphosphines
  94. Bridged poly(1-imidazolyl)borate silver(I) complexes containing tertiary mono(phosphine) ligands. The first structurally authenticated bis(imidazolyl)borate metal complex †
  95. Synthesis, characterization and X-ray structural studies of novel dinuclear silver(I) complexes of poly(azolyl)borate ligands
  96. Synthesis, structural and spectroscopic characterization of new silver(I) poly(pyrazolyl)borate complexes containing isonitrile ligands
  97. Synthesis, spectroscopic characterization, and structural systematics of new triorganophosphinecopper(I) poly(pyrazol-1-yl)borate complexes †
  98. Synthesis, characterization and crystal structure of new copper(II) complexes with tris- and tetrakis-(pyrazol-1-yl)borate ligands
  99. New phosphino silver(I) derivatives of hydrotris(3-methyl-2-thioxo-1-imidazolyl)borate. X-ray crystal structure of tricyclohexylphosphinesilver(I)-hydrotris(3-methyl-2-thioxo-1-imidazolyl)borate
  100. IR and Raman Spectroscopy of Inorganic, Coordination and Organometallic Compounds*
  101. Coordination chemistry of the sterically hindered N3-donor hydrotris(3,5-diphenylpyrazol-1-yl)borate toward silver(I)triorganophosphino compounds. Synthesis, structural and spectroscopic characterization
  102. Tin (IV) and organotin (IV) complexes containing mono or bidentate N-donor ligands. V. Imidazole and imidazoline-2-thione derivatives: synthesis and spectroscopic characterization. Comparison with other imidazole tin (IV) complexes
  103. Viscoelastic investigation by ultrasonic shear waves of liquid eutectic mixture methylurea–ammonium sulfamate
  104. Silver(I) and gold(I) complexes of hydrotris(3,5-dimethylpyrazol-1-yl)borate: synthesis, spectroscopic and structural characterization, and reactivity toward C-, N- and S-donor ligands.
  105. Syntheses and Spectroscopic and Structural Characterization of Silver(I) Complexes Containing Tertiary Phosphines and Hydrotris(pyrazol-1-yl)-, Hydrotris(4-bromopyrazol-1-yl)-, Hydrotris(3,5-dimethypyrazol-1-yl)-, and Hydrotris(3-methyl-2-thioxo-1-imid...
  106. Metal polypyrazolylborates
  107. Variable co-ordination numbers in 1∶1 adducts of silver(I) tetrakis(pyrazolyl)borates with tertiary phosphines
  108. Tin(IV) and organotin(IV) complexes containing mono or bidentate N-donor ligands—IV. 2-methyl-, 2-isopropyl- and 4-methyl-imidazole derivatives: synthesis, characterization and behaviour in solution
  109. Tris(4-bromo-1H-pyrazol-1-yl)borato derivatives of first-row transition and group 12 and 14 metals. X-ray crystal structure of [HB(4-Brpz)3]2 Cd. 113Cd solution NMR study of bis[poly(pyrazolyl)borato]cadmium complexes
  110. Synthesis and characterization of copper(I) derivatives with N-donor ligands—IV. Poly (1H-pyrazol-1-yl)borates cyclohexylphosphine CuI, the X-ray crystal structures of [HB-(μ-pz)3-CuP(Cy)3] and [HB-(μ-3,5 Me2pz)3-CuP(Cy)3]
  111. Zinc(II), cadmium(II) and mercury(II) derivatives of bis(4-halopyrazol-1-yl)alkanes: synthesis, spectroscopic characterization and behaviour in solution
  112. Organotin(IV) polypyrazolylborates. XII. Hydridotris(4-bromo-1H-pyrazol-1-yl) borates: characterization, Mössbauer study and X-ray crystal structure of MeCl2Sn(4-BrPz)3BH
  113. Metal polypyrazolylborates. X. Thienylmercury(II) derivatives: the X-ray crystal structure of [(5-Me) Thien-2-yl]Hg-(ν-Pz)2B(Pz)2
  114. Organotin(IV) polypyrazolylborates. IX. Tetrakis(4-methyl-1 H-pyrazol-l-yl)borates. Characterisation, Mössbauer study and X-ray crystal structure of Cl3Sn(μ-4-MePz)3B(4-MePz)
  115. Trichloro-, mono-, di- and tri-organotin(IV) derivatives of hydridotris(4-methylpyrazol-1-yl)borates
  116. Synthesis and characterization of some zinc, cadmium and mercury(II) derivatives of bis(4-methylpyrazol-1-yl) alkanes